Press Releases

 Filter by Provider

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the following investor conference:

Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”), one of the fastest-growing brands in the U.S. quick service beverage industry, today reported financial results for the third quarter ended September 30, 2026.

SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (NASDAQ: ECPG), an international specialty finance company, today reported consolidated financial results for the third quarter ended September 30, 2026.

MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the third quarter ended September 30, 2026 and raised guidance for full year 2026.

ENERGY STORAGE DRIVES DOUBLE-DIGIT GROWTH; ORMAT RAISES MIDPOINT OF 2026 REVENUE AND ADJUSTED EBITDA GUIDANCE AND EXPANDS EGS PIPELINE POTENTIAL TO 5–6 GW

Send volume up 25% and revenue up 22% year over yearNet income of $67.6 million up 665% year over yearAdjusted EBITDA of $120.8 million up 97% year over yearBoard of directors increases share repurchase authorization from $200 million to $500 million

Highlights

- Revenues up 5% to $334.1 Million and Gross Billings up 3% to $2.40 Billion -

Fremont, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be participating in the following investor conferences:

VAX-31 Adult Indication: Announced Positive Topline Data from OPUS-1 Pivotal Phase 3 Trial; VAX-31 Met All Prespecified Primary Endpoints, Was Well Tolerated and Demonstrated a Safety Profile Similar to PCV20 and PCV21 Across All Ages Studied

MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Wolfe Research Wealth Symposium on Wednesday, November 11, 2026.

CLEVELAND, OH / ACCESS Newswire / November 4, 2026 / Mike Orakpo learned the math of expensive real estate the hard way. He put about 20% down on a roughly $420,000 duplex in the Dallas-Fort Worth area, close to $50,000 out of pocket. In some months, it netted him less than $200. Then he looked at Cleveland, where duplexes in decent neighborhoods were selling for about $50,000. That is roughly what he had put down on a single property in Texas.

Chesapeake Granite Wash Trust (OTCID Basic Market: CHKR) (the “Trust”) today announced that its common unit distribution for the quarter ended September 30, 2026 (which primarily relates to production attributable to the Trust’s royalty interests from June 1, 2026 through August 31, 2026) will be $0.0154 per common unit. The distribution will be paid on November 30, 2026 to common unitholders of record at the close of business on November 19, 2026.

Onterris, Inc. (the “Company,” “Onterris” or “ONT”) (NYSE: ONT), a global environmental solutions company solving complex challenges for planet and progress, today announced results for the third quarter ended September 30, 2026.

KING OF PRUSSIA, Pa., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), the Decision-to-Defense™ global indirect tax and compliance company, today announced financial results for its third quarter ended September 30, 2026.

Niagen Bioscience, Inc. (NASDAQ:NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced its operational updates and financial results for the third quarter of 2026.

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced that its Board of Directors declared a quarterly base cash dividend of $0.16 per share of Class A common stock, or $0.64 per share on an annualized basis. The base dividend is payable on December 31, 2026 to shareholders of record as of December 17, 2026.

8x8, Inc. (NASDAQ: EGHT), a leading global business communications platform provider, released its Q2 FY27 momentum metrics, reporting a 232% year over year increase in customer adoption of its AI solutions, including 8x8 AI Studio, 8x8 Intelligent Customer Assistant, and 8x8 Smart Assist, among others.

Third Quarter 2026 Highlights:

  

– Data presentation to include safety, pharmacokinetics (PK), and pharmacodynamics (PD) from all patients, with preliminary efficacy from patients with T-cell lymphomas, in patients with relapsed/refractory non-Hodgkin lymphoma (NHL) –

ORLANDO, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT) (“PureCycle” or the “Company”), a U.S.-based company revolutionizing plastic recycling, today announced results for the third quarter ended September 30, 2026.

Third quarter 2026 total revenue was $12.7 million, up 22% over the same quarter prior yearCompany raises 2026 revenue guidance to $46-48 millionStrengthened balance sheet with $46 million public equity offering completed in October 2026

DT-216P2 Anticipated Milestones: Registrational Plan Update in Q4 2026 and 12-Week RESTORE-FA Data in Q1 2027

SAN FRANCISCO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema�� or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced it will present clinical data from the Phase 1b/2 study of OP-3136 in combination with fulvestrant, the Phase 1b/2 study of palazestrant in combination with everolimus, and the Phase 1b study of palazestrant in combination with atirmociclib in poster presentations at the San Antonio Breast Cancer Symposium (SABCS) taking place December 8-11 in San Antonio, TX.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the third quarter ended September 30, 2026.

Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net IncomeSelling Season Yields Record 1.3 Million New Covered Lives with Another Year of Near 100% Retention Raises Midpoint of Full Year Guidance Ranges

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on November 4, 2026, the Company granted inducement awards to purchase up to 213,500 shares of common stock to five new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

Robust sales growth continued in our direct business

Lumen Technologies, Inc. (Nasdaq: LUMN) today reported third quarter 2026 results, delivering strong Strategic revenue growth and remaining on track for the adjusted EBITDA inflection in 2026. The company continues progress toward its financial goals and strategic transformation with expanded adoption of its Network-as-a-Service (NaaS) platform and advanced portfolio simplification.

Power Integrations (NASDAQ: POWI) today announced financial results for the quarter ended September 30, 2026. Revenue for the third quarter was $125.5 million, up five percent from the prior quarter and up six percent from the third quarter of 2025. GAAP net income for the third quarter was $18.3 million or $0.32 per diluted share compared to $0.17 per diluted share in the prior quarter and a net loss of $0.02 per diluted share in the third quarter of 2025. Cash flow from operations for the third quarter was $42.6 million.

MercadoLibre, Inc. (NASDAQ: MELI) (http://www.mercadolibre.com) today reported financial results for its third fiscal quarter ended September 30, 2026, in a Letter to Shareholders, which is now posted to the company’s Investor Relations website at https://investor.mercadolibre.com.

Gulfport Energy Corporation (NYSE: GPOR) (“Gulfport” or the “Company”) today reported financial and operating results for the three months ended September 30, 2026.

PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced the grant of inducement equity awards to four newly hired non-executive employees as a material inducement to commencing their employment with the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Advancing a neuromuscular franchise with claseprubart, a highly potent, investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN)

HAMPTON, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming investor conferences:

OG Health in Greenwood Village honors the Army service of owner Dr. Ozzie Grenardo’s parents and its team’s military families while thanking local veterans.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced a price increase for select polyamide and polyester products sold in Asia. This adjustment reflects ongoing cost increases and evolving market conditions, enabling Celanese to maintain reliable supply, consistent product quality and high levels of customer service.

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the third quarter ended September 30, 2026, after the close of the U.S. capital markets on Wednesday, November 11, 2026.

WESTLAKE VILLAGE, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter ended September 30, 2026, and provided a business update.

Dare 2 Dream Mortgage Company in Coquitlam, BC, has expanded its reverse mortgage solutions for seniors aged 55+. The specialized service enables local homeowners to convert property equity into tax-free cash with no monthly repayments, helping them safely age in place.

Median home prices rose in four of five North Georgia mountain counties in the year to September 2026, Gold Peach Realty's Georgia MLS reports show. Homes for sale equaled 9.7 to 12.9 months of sales.

New 2027 outlook finds payer leaders reassessing outsourcing, offshoring, nearshoring and insourcing as automation, interoperability mandates and rising administrative expense redefine the economics of managed care

AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will present at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026 at 9:30 am GMT and members of management will be available for 1x1 meetings.

Fortive Corporation (“Fortive”) (NYSE: FTV) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.07 per share of its common stock, par value $0.01 per share, payable on December 28, 2026, to stockholders of record on November 27, 2026. Although Fortive expects to pay dividends on a quarterly basis, any subsequent declaration of dividends, including the amount, the record dates, and the payment dates for any such future dividend payments, is subject to the discretion of the Board of Directors.

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether the directors of Distribution Solutions Group, Inc. (NASDAQ: DSGR) approved a buyout of Distribution Solutions Group for inadequate consideration, breaching their fiduciary duties to Distribution Solutions Group’s shareholders, and whether Distribution Solutions Group’s shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

Benton, Arkansas--(Newsfile Corp. - November 4, 2026) - Arkansas Governor Sarah Huckabee Sanders recently visited the CoorsTek manufacturing facility in Benton as part of her Capital for a Day initiative, which designated Benton as Arkansas' temporary state capital for the day. The visit showcased the facility's advanced manufacturing capabilities and the skilled employees who produce critical ceramic components for defense and other industrial applications.

Generational Group, a leading investment banking firm for privately held businesses, is honored to have served as title sponsor of the 12th Annual Generational Salute – A Tribute to Our Troops, an annual fundraising event dedicated to honoring veterans and supporting organizations that serve members of the military community.

NEW YORK CITY, NY / ACCESS Newswire / November 4, 2026 / Carpenter Technology Corporation (NYSE:CRS) shareholders lost as much as $75.93 per share -- 20.62% -- during intraday trading on October 22, 2026, after the Company reported first quarter 2027 earnings. If you lost money on your Carpenter Technology investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.